Cross Country Healthcare (CCRN) Tops Q3 EPS by 27c
Cross Country Healthcare (NASDAQ: CCRN) reported Q3 EPS of $0.61, $0.27 better than the analyst estimate of $0.34. Revenue for the quarter came in at $374.9 million versus the consensus estimate of $320.47 million.
GUIDANCE:
Cross Country Healthcare sees Q4 2021 EPS of $1.01-$1.11. Cross Country Healthcare sees Q4 2021 revenue of $580-590 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
